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Thank you for your interest in this study, the results of which 
showed that there is no substantial difference in bone mineral 
density (BMD) T-score measured using a quantitative ultra-
sound (QUS) between control and prediabetic men between 
40 and 70 years of age [1].
  The calcaneal QUS is an evaluation tool used to detect os-
teoporosis and risk of fractures based on measurements of the 
foot. It is very useful for clinical application due to its low-cost 
and high-mobility [2]. Generally, broadband ultrasound atten-
uation (BUA) and the speed of sound (SOS) are measured and 
used to calculate BMD. However, in this study, there was a lim-
itation for that data which cannot be presented through a loss 
of data for BUA and SOS results. Dual-energy X-ray absorpti-
ometry (DXA) has been used as a method to measure BMD [3]. 
However, due to radiation exposure or mobility restrictions, 
different examination methods are used to evaluate BMD and 
risk of fractures depending on the situation. In the case of epi-
demiologic studies like this one, QUS is used to determine 
BMD. There have been many reports that the t-scores derived 
from QUS measurements are correlated with the t-scores de-
rived from DXA measurements [4-6]. In addition, the results 
of QUS measurements have been expressed as BMD in several 
studies [4,7,8]. Although DXA is the golden standard for mea-
suring BMD, 100% accuracy in reflecting the real physiologi-
cal state has not been achieved. Although ‘t-score assessed by 
QUS’ is a more accurate representation of our measurement 
than is BMD, we can use BMD as broader meaning when con-
sidering the correlation between QUS and DXA. 
  It is a well known fact that insulin has an anabolic effect on 
bone cells [9,10]. As noted in your comment, the correlation 
between insulin and BMD showed confusing results in this 
study [1]. As indicated, statistical limitations or non-linear re-
lationships are likely to be seen. The BMD in type 2 diabetes 
patients have reported conflicting results according to the study 
subjects or age groups [11-13]. Because we targeted the afore-
mentioned prediabetic patient group, the BMD in diabetes pa-
tients could be projected through this study; however, there 
was no observed significant difference between prediabetic 
subjects and the control group. 
  The participants in this study were males between 40 and 70 
years of age. Many factors that have an effect on BMD were 
not considered in this study; therefore, we believe that a pro-
spective control study is required to overcome this limitation. 
This study is the first to analyze BMD in Korean prediabetic 
patients, and the results are expected to be clinically useful. 
  We would like to thank you once again for your comments 
and interest in this study.
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